Phase 1 Study of Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia

Trial Profile

Phase 1 Study of Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia

Completed
Phase of Trial: Phase I/II

Latest Information Update: 10 Dec 2013

At a glance

  • Drugs DCP 001 (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 28 May 2013 Clinical endpoints met (safety, feasability and positive immune response), according to CDPrime media release.
    • 28 May 2013 Status changed from recruiting to completed, according to a DCPrime media release.
    • 21 Feb 2012 Planned End Date changed from 1 Jul 2013 to 1 Sep 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top